KANKF

Basic Materials Specialty Chemicals

Kaneka Corporation

$30.28
+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap
1.82B
Avg Volume
0
P/E (TTM)
10.89
EPS
$2.78
52W High
$30.28
52W Low
$24.90
Div. Yield
528.5%

Valuation

P/B Ratio
0.56
P/S Ratio
0.00
EV/EBITDA
2.30
EV/Revenue
0.24

Margins

Gross Margin 28.3%
Operating Margin 6.7%
Net Margin 4.3%
EBITDA Margin 10.4%

Growth & Returns

Revenue Growth (YoY)
12.3%
Earnings Growth (YoY)
119.0%
Earnings Growth (QoQ)
109.8%
Return on Equity
7.4%
Return on Assets
2.5%

Liquidity & Leverage

Current Ratio
1.50
Quick Ratio
0.72
Debt / Equity
0.43
Total Cash
52.58B
Total Debt
227.06B

About

Kaneka Corporation engages in the manufacture and sale of polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan, Asia, North America, Europe, and internationally. It offers impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, biodegradable polymer, engineering resin for injection molding, acrylic film, and isobutylene-based thermoplastic elastomer products. The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products. In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; and organic EL lighting panels, lithium-ion battery, and biosurfactant. Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad. Additionally, it provides dairy products, yogurt, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, which include coenzyme, probiotics, and dietary ingredients, as well as fertilizers. The company was incorporated in 1949 and is headquartered in Tokyo, Japan.

www.kaneka.co.jp